1、 ZHONG J,HE X,GAO X,et al.Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling[J].Nat Commun,2023,14(1):5451. ZHONG J,HE X,GAO X,et al.Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling[J].Nat Commun,2023,14(1):5451.
2、 ZHANG L,LI Y,WANG Y,et al.mTORC2 facilitates liver regeneration through sphingolipid-induced PPAR-α-fatty acid oxidation[J].Cell Mol Gastroenterol Hepatol,2022,14(6):1311-1331. ZHANG L,LI Y,WANG Y,et al.mTORC2 facilitates liver regeneration through sphingolipid-induced PPAR-α-fatty acid oxidation[J].Cell Mol Gastroenterol Hepatol,2022,14(6):1311-1331.
3、 YANG W,LING X,HE S,et al.PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances:An integrated approach[J].Environ Int,2023,178:108138. YANG W,LING X,HE S,et al.PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances:An integrated approach[J].Environ Int,2023,178:108138.
4、 ZHANG F M,JIANG X,LI S,et al.Simplified calculation of bile cholesterol saturation index[J].Hepatobiliary Pancreat Dis Int,2022,21(3):293-294. ZHANG F M,JIANG X,LI S,et al.Simplified calculation of bile cholesterol saturation index[J].Hepatobiliary Pancreat Dis Int,2022,21(3):293-294.
5、 XIA Y,XU Y,LIU Q,et al.Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylation[J].Metabolism,2023(145):155610. XIA Y,XU Y,LIU Q,et al.Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylation[J].Metabolism,2023(145):155610.
6、 ALMOHAWES Z N,EL-KOTT A,MORSY K,et al.Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats[J].Arch Physiol Biochem,2024,130(3):257-274. ALMOHAWES Z N,EL-KOTT A,MORSY K,et al.Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats[J].Arch Physiol Biochem,2024,130(3):257-274.
7、 CHEN Z,SHAO W,LI Y,et al.Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPARα-mediated CYP7A1 activation[J].Metabolism,2024(152):155774. CHEN Z,SHAO W,LI Y,et al.Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPARα-mediated CYP7A1 activation[J].Metabolism,2024(152):155774.
8、 GALLUCCI G M,HAYES C M,BOYER J L,et al.PPAR-mediated bile acid glucuronidation:Therapeutic targets for the treatment of cholestatic liver diseases[J].Cells,2024,13(15):1296. GALLUCCI G M,HAYES C M,BOYER J L,et al.PPAR-mediated bile acid glucuronidation:Therapeutic targets for the treatment of cholestatic liver diseases[J].Cells,2024,13(15):1296.
9、 FAN N,MENG K,ZHANG Y,et al.The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models[J].Lipids Health Dis,2020,19(1):158. FAN N,MENG K,ZHANG Y,et al.The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models[J].Lipids Health Dis,2020,19(1):158.
10、 CHOI Y J,YANG H S,ZHANG Y,et al.Intratracheal exposure to polyhexamethylene guanidine phosphate disrupts coordinate regulation of FXR-SHP-mediated cholesterol and bile acid homeostasis in mouse liver[J].Ecotoxicol Environ Saf,2022(247):114213. CHOI Y J,YANG H S,ZHANG Y,et al.Intratracheal exposure to polyhexamethylene guanidine phosphate disrupts coordinate regulation of FXR-SHP-mediated cholesterol and bile acid homeostasis in mouse liver[J].Ecotoxicol Environ Saf,2022(247):114213.
11、 YE X,SHEN S,XU Z,et al.Sodium butyrate alleviates cholesterol gallstones by regulating bile acid metabolism[J].Eur J Pharmacol,2021(908):174341. YE X,SHEN S,XU Z,et al.Sodium butyrate alleviates cholesterol gallstones by regulating bile acid metabolism[J].Eur J Pharmacol,2021(908):174341.
12、 FARHAT D,REZAEI F,RISTOVSKI M,et al.Structural analysis of cholesterol binding and sterol selectivity by ABCG5/G8[J].J Mol Biol,2022,434(20):167795. FARHAT D,REZAEI F,RISTOVSKI M,et al.Structural analysis of cholesterol binding and sterol selectivity by ABCG5/G8[J].J Mol Biol,2022,434(20):167795.
13、 SHARMA B,SHARMA S R.Evaluation of gallstone classification and their diagnosis through serum parameters as emerging tools in treatment:A narrative review[J].Postgrad Med,2022,134(7):644-653. SHARMA B,SHARMA S R.Evaluation of gallstone classification and their diagnosis through serum parameters as emerging tools in treatment:A narrative review[J].Postgrad Med,2022,134(7):644-653.
14、 JIN C G,JIANG F R,ZHANG J,et al.Role of osteopontin in diet-induced brown gallstone formation in rats[J].Chin Med J,2021,134(9):1093-1100. JIN C G,JIANG F R,ZHANG J,et al.Role of osteopontin in diet-induced brown gallstone formation in rats[J].Chin Med J,2021,134(9):1093-1100.
15、 SUN H,WARREN J,YIP J,et al.Factors influencing gallstone formation:A review of the literature[J].Biomolecules,2022,12(4):550. SUN H,WARREN J,YIP J,et al.Factors influencing gallstone formation:A review of the literature[J].Biomolecules,2022,12(4):550.
16、 ZHANG C,DAI W,YANG S,et al.Resistance to Cholesterol Gallstone Disease:Hepatic Cholesterol Metabolism[J].J Clin Endocrinol Metab,2024,109(4):912-923. ZHANG C,DAI W,YANG S,et al.Resistance to Cholesterol Gallstone Disease:Hepatic Cholesterol Metabolism[J].J Clin Endocrinol Metab,2024,109(4):912-923.
